Skip to main content

Health condition

Hughes syndrome, the autoimmune thrombophilia behind clots and recurrent miscarriage.

Also called antiphospholipid syndrome. Treatable, testable and often missed - a stepped rheumatology and haematology plan changes lives.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against BSR, EULAR, BSH and the updated 2023 ACR/EULAR criteria you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK practice including the TRAPS trial and specialist commissioned pregnancy pathways.

Key facts

Hughes syndrome at a glance.

The essentials, in plain English - what it is, the antibodies that define it and how the UK treats it today.

  • What it is

    An autoimmune thrombophilia with persistent antiphospholipid antibodies plus thrombosis or pregnancy morbidity. Named for Professor Graham Hughes, London 1983.

  • The antibodies

    Lupus anticoagulant, anticardiolipin (IgG or IgM) and anti-beta-2 glycoprotein 1 - positive on two occasions, twelve weeks apart.

  • Primary or secondary

    Primary APS stands alone. Secondary APS is linked to lupus or other autoimmune disease and needs joint rheumatology and haematology input.

  • Types

    Venous, arterial and microvascular disease - each behaves and is anticoagulated differently.

  • Pregnancy

    Recurrent miscarriage, pre-eclampsia and stillbirth define the obstetric side. Low molecular weight heparin plus aspirin markedly improves live birth rates.

  • Catastrophic APS

    Rare but life-threatening - multi-organ microvascular thrombosis needing specialist commissioned emergency care.

Why this guide matters

A treatable cause of clots and miscarriage - often missed.

APS is one of the most treatable autoimmune diseases if it is recognised. The three points below shape everything else on this page.

  • Antibodies define the disease

    Lupus anticoagulant, anticardiolipin and anti-beta-2 glycoprotein 1 - positive twice, twelve weeks apart. Anything less is not APS.

  • Anticoagulation is lifelong

    After a qualifying clot, warfarin at target INR is usually for life. Stopping early is the commonest reason for recurrence.

  • Pregnancy is winnable

    With LMWH plus aspirin in a specialist commissioned service, live birth rates rise from around one in three to more than seven in ten.

How the diagnosis is made

From first clot or loss to a clear plan.

The steps a UK rheumatology, haematology or obstetric team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Clinical criteria

    A qualifying event - venous, arterial or microvascular thrombosis, or defined pregnancy morbidity - per the 2023 ACR/EULAR criteria.

  2. 02

    Assessing

    Antibody panel

    Lupus anticoagulant, IgG and IgM anticardiolipin and IgG and IgM anti-beta-2 glycoprotein 1. Triple positivity carries the highest risk.

  3. 03

    Assessing

    Repeat at twelve weeks

    A single positive result is not diagnostic. Persistence on a second sample at least twelve weeks later is required to confirm APS.

  4. 04

    Confirming

    Lupus and autoimmune workup

    ANA, dsDNA, complement and extractable antibodies help distinguish primary from secondary APS - and shape long-term follow-up.

  5. 05

    Confirming

    Baseline safety bloods

    Full blood count, coagulation screen, renal and liver function and urinalysis - thrombocytopenia, anaemia and renal involvement are common.

  6. 06

    Preparing

    Imaging where indicated

    MRI brain for cognitive symptoms, migraine or suspected stroke. Doppler, CTPA or echo as the clinical picture demands.

  7. 07

    Preparing

    Specialist MDT review

    A specialist commissioned rheumatology, haematology and - where relevant - obstetric MDT sets the anticoagulation and monitoring plan.

Typical timeline: from event to confirmed diagnosis and settled plan across roughly three months.

Symptoms

What Hughes syndrome actually looks like.

Thrombosis, pregnancy loss and a scatter of extra-criteria features - livedo, migraine, cognitive slips and valvular disease.

  • Deep vein thrombosis

    The commonest venous event - unilateral leg swelling and pain. See our guide on deep vein thrombosis.

  • Pulmonary embolism

    Sudden breathlessness, pleuritic pain or collapse - a life-threatening presentation that needs immediate assessment.

  • Stroke and TIA

    Arterial thrombosis, often in younger adults. Compare with haemorrhagic stroke where the mechanism differs.

  • Recurrent miscarriage

    Three or more early losses, or one late loss - a defining obstetric feature and a reason to test.

  • Pre-eclampsia and IUGR

    Placental insufficiency, growth restriction and severe pre-eclampsia before 34 weeks.

  • Livedo reticularis and racemosa

    A lace-like or broken netted pattern on the skin - extra-criteria but strongly associated, particularly in Sneddon syndrome.

  • Cognitive symptoms and migraine

    Brain fog, memory slips and severe migraine - often the earliest whisper before a clot event.

  • Red flag - catastrophic APS

    Multi-organ failure over days from widespread small-vessel clotting - an emergency needing specialist commissioned care.

Treatment

How Hughes syndrome is treated in the UK.

Aspirin for prevention, warfarin for most established clots, LMWH for pregnancy and specialist commissioned care for catastrophic disease.

  • Low-dose aspirin

    75 mg daily for primary prevention in high-risk profiles - triple positivity or coexisting lupus - per BSR guidance.

  • Warfarin - venous APS

    Lifelong anticoagulation targeting INR 2 to 3 after a first venous event. The mainstay for most patients.

  • Warfarin - arterial APS

    Higher target INR 3 to 4 after arterial events or in high-risk profiles, balanced against bleeding risk.

  • DOACs - selective use

    Rivaroxaban and apixaban have a limited role. Not recommended for triple-positive APS after the TRAPS trial - specialist commissioned decision.

  • LMWH plus aspirin - pregnancy

    The evidence-based combination for obstetric APS - improves live birth rates markedly. Managed in a specialist commissioned high-risk pregnancy service.

  • Catastrophic APS - triple therapy

    Anticoagulation, high-dose steroids and plasma exchange or IVIG, with rituximab in refractory cases. Specialist commissioned emergency care.

  • Emerging - biologics

    Rituximab, belimumab and tocilizumab are used selectively in refractory or secondary APS within specialist centres.

  • Lifestyle and risk reduction

    Stop smoking, avoid oestrogen-containing contraception, control blood pressure and cholesterol - each layers meaningful protection.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your rheumatology, haematology or obstetric team knows your history and can tell you which parts apply to you. If in doubt, get seen.

  • British Society for Rheumatology (BSR). Guideline for the management of antiphospholipid syndrome.

  • EULAR. Recommendations for the management of antiphospholipid syndrome in adults.

  • British Society for Haematology (BSH). Investigation and management of antiphospholipid syndrome.

  • ACR/EULAR. 2023 classification criteria for antiphospholipid syndrome.

  • TRAPS trial (Blood, 2018). Rivaroxaban vs warfarin in high-risk APS - stopped early for harm.

  • NHS England. Specialised rheumatology and specialised commissioning framework.

Red flags

When APS needs urgent attention.

Most APS is managed in specialist clinics between events. These are the situations that demand immediate escalation.

  • Catastrophic APS

    Rapid multi-organ failure with microvascular thrombosis - transfer to a specialist commissioned centre for triple therapy without delay.

  • Stroke or TIA under 50

    A younger arterial event without conventional risk factors should prompt APS testing alongside standard stroke workup.

  • Recurrent unprovoked VTE

    A second unprovoked venous event, particularly at unusual sites like Budd-Chiari or adrenal veins, warrants thrombophilia review.

  • Late fetal loss or severe pre-eclampsia

    Stillbirth after ten weeks, or severe pre-eclampsia before 34 weeks - both are formal criteria and mandate testing.

  • Livedo racemosa

    The broken netted skin pattern - especially with neurological events - suggests Sneddon syndrome, an APS variant.

  • Persistent thrombocytopenia

    Low platelets alongside clotting events is a paradox worth investigating - and part of the extra-criteria features.

  • INR instability

    Fluctuating INRs on warfarin are common in APS - a lupus anticoagulant can interfere with the assay. Discuss chromogenic monitoring.

  • Pregnancy planning

    Warfarin is teratogenic. Any woman with APS considering pregnancy needs specialist commissioned counselling before conception.

Living with it

A manageable condition, with the right team around you.

Four things that make the biggest difference day to day - adherence, monitoring, avoiding oestrogen and planning pregnancy well in advance.

A quiet reminder

The Hughes Syndrome Foundation and APS Support UK are worth knowing.

Patient charities offer helplines, printable INR diaries and peer connection - a quiet but powerful supplement to your clinical care.

  1. 01 Adherence

    Take anticoagulation seriously

    Missed doses matter. Set a routine, use a pillbox and keep a yellow book handy for warfarin. Consistency prevents clots.

  2. 02 Monitor

    Know your INR

    Aim for the target your team sets - usually 2 to 3, higher for arterial events. Frequent monitoring is the price of protection.

  3. 03 Avoid

    Skip the oestrogen

    Combined oral contraception and hormone replacement raise clot risk. Progesterone-only or non-hormonal options are safer.

  4. 04 Plan

    Plan pregnancy in advance

    Preconception review sets you up for a good outcome. LMWH replaces warfarin and a specialist commissioned team supervises throughout.

Frequently asked

Everything we get asked about Hughes syndrome.

Quick answers on diagnosis, anticoagulation, pregnancy and catastrophic APS.

  • What is Hughes syndrome?

    Hughes syndrome, also called antiphospholipid syndrome or APS, is an autoimmune condition in which the immune system makes antibodies against phospholipid-binding proteins. Those antibodies drive blood clotting and pregnancy complications. It was described by Professor Graham Hughes in London in 1983.

  • How is APS diagnosed?

    Diagnosis needs a qualifying clinical event - venous, arterial or microvascular thrombosis, or defined pregnancy morbidity - plus persistently positive antiphospholipid antibodies. That means lupus anticoagulant, anticardiolipin or anti-beta-2 glycoprotein 1 antibodies positive on two occasions at least twelve weeks apart, per the 2023 ACR/EULAR criteria.

  • What is the difference between primary and secondary APS?

    Primary APS occurs on its own. Secondary APS accompanies another autoimmune disease, most commonly systemic lupus erythematosus. The antibody profile and thrombotic risk can be similar, but secondary APS needs coordinated rheumatology and haematology care to manage the underlying autoimmune disease as well.

  • Can I use a DOAC instead of warfarin?

    Sometimes, but with caution. The TRAPS trial showed rivaroxaban was inferior to warfarin in triple-positive APS and it is not recommended in that group. DOACs may be considered in selected low-risk patients, but the decision is a specialist commissioned one and warfarin remains the default for most.

  • What does APS mean for pregnancy?

    Untreated APS is linked to recurrent miscarriage, growth restriction, pre-eclampsia and stillbirth. Treatment with low molecular weight heparin plus low-dose aspirin, started early and continued through pregnancy and the postnatal period, substantially improves the live birth rate. Care is delivered in a specialist commissioned high-risk pregnancy service.

  • What is catastrophic APS?

    Catastrophic APS, or CAPS, is a rare and life-threatening variant with rapid multi-organ small-vessel thrombosis - kidneys, brain, heart, lungs and skin can fail within days. It needs specialist commissioned emergency care with anticoagulation, high-dose steroids, plasma exchange or IVIG and sometimes rituximab.

Related content

Keep reading.